Buprenorphine Neuraxpharm is a medicine used to treat dependence on opioid (narcotic) drugs such as heroin or morphine. It is used in adults and adolescents aged 15 years and above who have agreed to be treated for addiction and who are also receiving medical, social and psychological support. Buprenorphine Neuraxpharm contains the active substance buprenorphine and is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance, but that it is given in a different way. The reference medicine for Buprenorphine Neuraxpharm is Subutex. Buprenorphine Neuraxpharm is available as a sublingual film (a film to be placed under the tongue), whereas Subutex is available as sublingual tablets or a solution for injection.
Therapeutic Indication
Substitution treatment of opioid drug dependence, within a comprehensive therapeutic monitoring framework of medical, social and psychological treatment. Treatment is intended for use in adults and adolescents 15 years of age and older, who have agreed to be treated for addiction.
Therapeutic Area (MeSH)
ATC Code
N07BC01
ATC Item
N/A
Pharmacotherapeutic Group
Other nervous system drugs
Active Substance (Summary)
INN / Common Names
EMA Name
Buprenorphine Neuraxpharm
Medicine Name
Buprenorphine Neuraxpharm
Aliases
N/ANo risk management plan link.
